SCHEMBL17035161

SCHEMBL17035161

O=P(c1ccccc1)(c1ccccc1)c1ccc(-c2ccc(-c3nc4ccccc4c4ccc5ccccc5c34)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 5/20 0.40
TOP2A P11388 1/20 0.36
LMNA P02545 3/20 0.35
PDE10A Q9Y233 2/20 0.35
TSHR P16473 1/20 0.35
KDM4E B2RXH2 3/20 0.34
GAA P10253 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
ADORA2A P29274 1/20 0.33
NUDT1 P36639 1/20 0.33
POLB P06746 1/20 0.33
HSP90AA1 P07900 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19009485 0.90 TOP2A (0.36) DHODHTOP2ALMNAKDM4EGAA
SCHEMBL18200623 0.89 DHODH (0.40) DHODHLMNAPDE10ATSHRKDM4E
SCHEMBL17034894 0.89 DHODH (0.40) DHODHLMNAPDE10ATSHRKDM4E
SCHEMBL18200622 0.89 DHODH (0.40) DHODHLMNAPDE10ATSHRKDM4E
SCHEMBL19009851 0.86 MAPT (0.37) DHODHTOP2ALMNAKDM4EGAA
SCHEMBL24609771 0.84 DHODH (0.40) DHODHLMNAPDE10ATSHRKDM4E
SCHEMBL17300231 0.84 DHODH (0.42) DHODHLMNAPDE10ATSHRKDM4E
SCHEMBL17914731 0.84 DHODH (0.42) DHODHLMNAPDE10ATSHRKDM4E
SCHEMBL24609613 0.82 DHODH (0.38) DHODHLMNAPDE10ATSHRKDM4E
SCHEMBL17403769 0.82 DHODH (0.45) DHODHLMNAPDE10ATSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 DHODH 2312/4885TOP2A 1555/4885LMNA 1598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.